HEADER TRANSFERASE 01-JAN-19 6QDB TITLE LEISHMANIA MAJOR N-MYRISTOYLTRANSFERASE IN COMPLEX WITH TITLE 2 THIENOPYRIMIDINE INHIBITOR IMP-0000081 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.3.1.97; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA MAJOR; SOURCE 3 ORGANISM_TAXID: 5664; SOURCE 4 GENE: NMT, LMJF_32_0080; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET28 DERIVATIVE KEYWDS TRANSFERASE, MYRISTOYLATION, BENZOTHIOPHENE, LEISHMANIA EXPDTA X-RAY DIFFRACTION AUTHOR J.A.BRANNIGAN REVDAT 3 24-JAN-24 6QDB 1 REMARK REVDAT 2 02-DEC-20 6QDB 1 JRNL REVDAT 1 06-MAY-20 6QDB 0 JRNL AUTH A.S.BELL,Z.YU,J.A.HUTTON,M.H.WRIGHT,J.A.BRANNIGAN,D.PAAPE, JRNL AUTH 2 S.M.ROBERTS,C.L.SUTHERELL,M.RITZEFELD,A.J.WILKINSON, JRNL AUTH 3 D.F.SMITH,R.J.LEATHERBARROW,E.W.TATE JRNL TITL NOVEL THIENOPYRIMIDINE INHIBITORS OF LEISHMANIA N JRNL TITL 2 -MYRISTOYLTRANSFERASE WITH ON-TARGET ACTIVITY IN JRNL TITL 3 INTRACELLULAR AMASTIGOTES. JRNL REF J.MED.CHEM. V. 63 7740 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32575985 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00570 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 74413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3918 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5139 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.24 REMARK 3 BIN R VALUE (WORKING SET) : 0.1860 REMARK 3 BIN FREE R VALUE SET COUNT : 286 REMARK 3 BIN FREE R VALUE : 0.2270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3354 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.10000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.063 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.035 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.849 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3771 ; 0.015 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5182 ; 2.155 ; 1.682 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 473 ; 6.522 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 204 ;32.795 ;22.353 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 628 ;14.922 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;20.674 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 474 ; 0.126 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2972 ; 0.014 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1717 ; 1.672 ; 1.202 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2161 ; 2.491 ; 1.805 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2054 ; 2.554 ; 1.435 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5793 ; 5.294 ;17.506 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 6QDB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1200013690. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 78331 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.15700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 4CGP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 1500, 0.2 M NACL, 0.1 M NA REMARK 280 CACODYLATE, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.43500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 ASN A 4 REMARK 465 PRO A 5 REMARK 465 SER A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 ASP A 9 REMARK 465 ALA A 10 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 231 CG - CD - NE ANGL. DEV. = 15.2 DEGREES REMARK 500 ARG A 304 CG - CD - NE ANGL. DEV. = -15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 135 28.12 -145.43 REMARK 500 VAL A 307 -66.19 -126.58 REMARK 500 HIS A 347 -137.81 -101.37 REMARK 500 GLU A 379 42.25 -75.61 REMARK 500 LEU A 381 -138.42 52.61 REMARK 500 LYS A 391 32.73 70.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1004 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LEU A 175 O REMARK 620 2 MYA A1001 O1A 156.3 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HWQ A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HWQ A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 1004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CGO RELATED DB: PDB REMARK 900 4CGO CONTAINS SAME PROTEIN COMPLEXED WITH A CLOSELY RELATED REMARK 900 INHIBITOR DBREF 6QDB A 1 421 UNP Q4Q5S8 Q4Q5S8_LEIMA 1 421 SEQRES 1 A 421 MET SER ARG ASN PRO SER ASN SER ASP ALA ALA HIS ALA SEQRES 2 A 421 PHE TRP SER THR GLN PRO VAL PRO GLN THR GLU ASP GLU SEQRES 3 A 421 THR GLU LYS ILE VAL PHE ALA GLY PRO MET ASP GLU PRO SEQRES 4 A 421 LYS THR VAL ALA ASP ILE PRO GLU GLU PRO TYR PRO ILE SEQRES 5 A 421 ALA SER THR PHE GLU TRP TRP THR PRO ASN MET GLU ALA SEQRES 6 A 421 ALA ASP ASP ILE HIS ALA ILE TYR GLU LEU LEU ARG ASP SEQRES 7 A 421 ASN TYR VAL GLU ASP ASP ASP SER MET PHE ARG PHE ASN SEQRES 8 A 421 TYR SER GLU GLU PHE LEU GLN TRP ALA LEU CYS PRO PRO SEQRES 9 A 421 ASN TYR ILE PRO ASP TRP HIS VAL ALA VAL ARG ARG LYS SEQRES 10 A 421 ALA ASP LYS LYS LEU LEU ALA PHE ILE ALA GLY VAL PRO SEQRES 11 A 421 VAL THR LEU ARG MET GLY THR PRO LYS TYR MET LYS VAL SEQRES 12 A 421 LYS ALA GLN GLU LYS GLY GLU GLY GLU GLU ALA ALA LYS SEQRES 13 A 421 TYR ASP GLU PRO ARG HIS ILE CYS GLU ILE ASN PHE LEU SEQRES 14 A 421 CYS VAL HIS LYS GLN LEU ARG GLU LYS ARG LEU ALA PRO SEQRES 15 A 421 ILE LEU ILE LYS GLU ALA THR ARG ARG VAL ASN ARG THR SEQRES 16 A 421 ASN VAL TRP GLN ALA VAL TYR THR ALA GLY VAL LEU LEU SEQRES 17 A 421 PRO THR PRO TYR ALA SER GLY GLN TYR PHE HIS ARG SER SEQRES 18 A 421 LEU ASN PRO GLU LYS LEU VAL GLU ILE ARG PHE SER GLY SEQRES 19 A 421 ILE PRO ALA GLN TYR GLN LYS PHE GLN ASN PRO MET ALA SEQRES 20 A 421 MET LEU LYS ARG ASN TYR GLN LEU PRO SER ALA PRO LYS SEQRES 21 A 421 ASN SER GLY LEU ARG GLU MET LYS PRO SER ASP VAL PRO SEQRES 22 A 421 GLN VAL ARG ARG ILE LEU MET ASN TYR LEU ASP SER PHE SEQRES 23 A 421 ASP VAL GLY PRO VAL PHE SER ASP ALA GLU ILE SER HIS SEQRES 24 A 421 TYR LEU LEU PRO ARG ASP GLY VAL VAL PHE THR TYR VAL SEQRES 25 A 421 VAL GLU ASN ASP LYS LYS VAL THR ASP PHE PHE SER PHE SEQRES 26 A 421 TYR ARG ILE PRO SER THR VAL ILE GLY ASN SER ASN TYR SEQRES 27 A 421 ASN LEU LEU ASN ALA ALA TYR VAL HIS TYR TYR ALA ALA SEQRES 28 A 421 THR SER ILE PRO LEU HIS GLN LEU ILE LEU ASP LEU LEU SEQRES 29 A 421 ILE VAL ALA HIS SER ARG GLY PHE ASP VAL CYS ASN MET SEQRES 30 A 421 VAL GLU ILE LEU ASP ASN ARG SER PHE VAL GLU GLN LEU SEQRES 31 A 421 LYS PHE GLY ALA GLY ASP GLY HIS LEU ARG TYR TYR PHE SEQRES 32 A 421 TYR ASN TRP ALA TYR PRO LYS ILE LYS PRO SER GLN VAL SEQRES 33 A 421 ALA LEU VAL MET LEU HET MYA A1001 63 HET HWQ A1002 23 HET HWQ A1003 23 HET MG A1004 1 HETNAM MYA TETRADECANOYL-COA HETNAM HWQ 3-[METHYL-[2-[METHYL(PIPERIDIN-4-YL)AMINO]THIENO[3,2- HETNAM 2 HWQ D]PYRIMIDIN-4-YL]AMINO]PROPANENITRILE HETNAM MG MAGNESIUM ION HETSYN MYA MYRISTOYL-COA FORMUL 2 MYA C35 H62 N7 O17 P3 S FORMUL 3 HWQ 2(C16 H22 N6 S) FORMUL 5 MG MG 2+ FORMUL 6 HOH *480(H2 O) HELIX 1 AA1 PHE A 14 GLN A 18 5 5 HELIX 2 AA2 THR A 23 LYS A 29 1 7 HELIX 3 AA3 THR A 41 ILE A 45 5 5 HELIX 4 AA4 ALA A 65 TYR A 80 1 16 HELIX 5 AA5 SER A 93 CYS A 102 1 10 HELIX 6 AA6 ILE A 107 ASP A 109 5 3 HELIX 7 AA7 PRO A 138 GLY A 149 1 12 HELIX 8 AA8 GLU A 150 LYS A 156 1 7 HELIX 9 AA9 LYS A 173 ARG A 176 5 4 HELIX 10 AB1 ARG A 179 ARG A 194 1 16 HELIX 11 AB2 ASN A 223 ILE A 230 1 8 HELIX 12 AB3 PRO A 236 PHE A 242 5 7 HELIX 13 AB4 ASN A 244 GLN A 254 1 11 HELIX 14 AB5 LYS A 268 SER A 270 5 3 HELIX 15 AB6 ASP A 271 ASP A 284 1 14 HELIX 16 AB7 SER A 293 LEU A 302 1 10 HELIX 17 AB8 PRO A 355 ARG A 370 1 16 HELIX 18 AB9 ASP A 382 VAL A 387 5 6 HELIX 19 AC1 LYS A 412 VAL A 416 5 5 SHEET 1 AA112 PHE A 56 TRP A 59 0 SHEET 2 AA112 HIS A 111 ARG A 116 -1 O ARG A 115 N GLU A 57 SHEET 3 AA112 LEU A 122 ARG A 134 -1 O LEU A 123 N VAL A 114 SHEET 4 AA112 ARG A 161 VAL A 171 -1 O GLU A 165 N VAL A 129 SHEET 5 AA112 ALA A 200 ALA A 204 1 O VAL A 201 N ILE A 166 SHEET 6 AA112 GLY A 393 TYR A 404 -1 O TYR A 402 N TYR A 202 SHEET 7 AA112 ALA A 213 SER A 221 -1 N TYR A 217 O GLY A 395 SHEET 8 AA112 VAL A 374 VAL A 378 -1 O MET A 377 N PHE A 218 SHEET 9 AA112 LEU A 340 ALA A 351 1 N ALA A 344 O ASN A 376 SHEET 10 AA112 LYS A 318 VAL A 332 -1 N TYR A 326 O TYR A 345 SHEET 11 AA112 VAL A 308 ASN A 315 -1 N PHE A 309 O PHE A 325 SHEET 12 AA112 LEU A 264 GLU A 266 -1 N ARG A 265 O VAL A 312 SHEET 1 AA210 PHE A 88 PHE A 90 0 SHEET 2 AA210 LYS A 318 VAL A 332 -1 O THR A 331 N ARG A 89 SHEET 3 AA210 LEU A 340 ALA A 351 -1 O TYR A 345 N TYR A 326 SHEET 4 AA210 VAL A 374 VAL A 378 1 O ASN A 376 N ALA A 344 SHEET 5 AA210 ALA A 213 SER A 221 -1 N PHE A 218 O MET A 377 SHEET 6 AA210 GLY A 393 TYR A 404 -1 O GLY A 395 N TYR A 217 SHEET 7 AA210 ALA A 200 ALA A 204 -1 N TYR A 202 O TYR A 402 SHEET 8 AA210 ARG A 161 VAL A 171 1 N ILE A 166 O VAL A 201 SHEET 9 AA210 LEU A 122 ARG A 134 -1 N VAL A 129 O GLU A 165 SHEET 10 AA210 GLY A 289 PRO A 290 -1 O GLY A 289 N ARG A 134 LINK O LEU A 175 MG MG A1004 1555 1555 2.72 LINK O1A MYA A1001 MG MG A1004 1555 1555 2.82 CISPEP 1 PRO A 209 THR A 210 0 -13.36 SITE 1 AC1 36 HIS A 12 ALA A 13 PHE A 14 TRP A 15 SITE 2 AC1 36 ASN A 79 TYR A 80 VAL A 81 PHE A 168 SITE 3 AC1 36 LEU A 169 CYS A 170 VAL A 171 ARG A 176 SITE 4 AC1 36 GLU A 177 LYS A 178 ARG A 179 LEU A 180 SITE 5 AC1 36 ALA A 181 PRO A 182 THR A 189 VAL A 192 SITE 6 AC1 36 TRP A 198 TYR A 202 THR A 203 LEU A 208 SITE 7 AC1 36 TYR A 404 MG A1004 HOH A1167 HOH A1170 SITE 8 AC1 36 HOH A1194 HOH A1206 HOH A1235 HOH A1324 SITE 9 AC1 36 HOH A1336 HOH A1344 HOH A1382 HOH A1434 SITE 1 AC2 10 PHE A 90 TYR A 92 GLY A 205 TYR A 217 SITE 2 AC2 10 HIS A 219 TYR A 345 LEU A 421 HWQ A1003 SITE 3 AC2 10 HOH A1159 HOH A1265 SITE 1 AC3 13 VAL A 81 GLU A 82 ASP A 83 PHE A 88 SITE 2 AC3 13 PHE A 90 PHE A 232 SER A 330 LEU A 341 SITE 3 AC3 13 ALA A 343 ASN A 376 ASP A 396 HWQ A1002 SITE 4 AC3 13 HOH A1116 SITE 1 AC4 6 LEU A 175 GLU A 177 LYS A 178 ARG A 179 SITE 2 AC4 6 LEU A 180 MYA A1001 CRYST1 47.860 90.870 53.200 90.00 111.92 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020894 0.000000 0.008408 0.00000 SCALE2 0.000000 0.011005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020262 0.00000